Genovac on Antibody Discovery
Customer SpotlightGenovac on Antibody Discovery MEET GenovacGoing Where Hybridoma Can’t In the recent webinar, Tackle Difficult Targets by Accessing Broad B Cell Diversity, Genovac demonstrated how the Optoâ„¢ Plasma B Discovery workflow can yield up to 10-times more hits than hybridoma campaigns against difficult membrane targets like GPCRs and other multi-pass transmembrane targets. The three …